Inactive Instrument
Tobira Therapeutics Inc Stock
Stocks
US88883P1012
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Michael
CEO | Chief Executive Officer | 55 | - |
Scott Reents
DFI | Director of Finance/CFO | 59 | - |
| Corporate Secretary | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.89% | +1.41% | +73.41% | +128.90% | 57.72B | |
| -3.80% | -6.24% | +67.04% | +86.36% | 52.65B | |
| +1.17% | +5.83% | +16.39% | +468.18% | 24.46B | |
| +0.38% | +1.33% | -14.32% | -11.76% | 23.84B | |
| -3.05% | +3.06% | +42.36% | -5.66% | 19.28B | |
| -0.36% | +5.38% | +44.61% | -26.43% | 17.8B | |
| +3.46% | +17.72% | +206.66% | +364.07% | 17.29B | |
| -6.73% | +9.90% | +36.04% | - | 15.28B | |
| +2.79% | +4.91% | +29.26% | +195.60% | 14.35B | |
| Average | -0.79% | +5.15% | +55.72% | +149.91% | 26.96B | |
| Weighted average by Cap. | -1.17% | +2.58% | +57.61% | +139.31% |
- Stock Market
- Stocks
- Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
